221 related articles for article (PubMed ID: 33828260)
1. The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO).
Lund CM; Vistisen KK; Olsen AP; Bardal P; Schultz M; Dolin TG; Rønholt F; Johansen JS; Nielsen DL
Br J Cancer; 2021 Jun; 124(12):1949-1958. PubMed ID: 33828260
[TBL] [Abstract][Full Text] [Related]
2. The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).
Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
BMC Cancer; 2017 Jun; 17(1):448. PubMed ID: 28659138
[TBL] [Abstract][Full Text] [Related]
3. Geriatric assessment and intervention in older vulnerable patients undergoing surgery for colorectal cancer: a protocol for a randomised controlled trial (GEPOC trial).
Dolin TG; Mikkelsen M; Jakobsen HL; Nordentoft T; Pedersen TS; Vinther A; Zerahn B; Vistisen KK; Suetta C; Nielsen D; Johansen JS; Lund CM
BMC Geriatr; 2021 Jan; 21(1):88. PubMed ID: 33516195
[TBL] [Abstract][Full Text] [Related]
4. Geriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making?
Antonio M; Saldaña J; Carmona-Bayonas A; Navarro V; Tebé C; Nadal M; Formiga F; Salazar R; Borràs JM
Oncologist; 2017 Aug; 22(8):934-943. PubMed ID: 28487465
[TBL] [Abstract][Full Text] [Related]
5. GERiatric Screening in the treatment of elderly patients with Ovarian Carcinoma (GERSOC): study protocol for a pragmatic, cluster randomised controlled trial.
van Soolingen NJ; Smorenburg CH; Hamaker ME; Groen WG; Retèl VP; Lok CAR; van de Poll-Franse LV; Trum JW
Trials; 2020 Feb; 21(1):214. PubMed ID: 32087750
[TBL] [Abstract][Full Text] [Related]
6. Factors Predicting Adherence to a Tailored-Dose Adjuvant Treatment on the Basis of Geriatric Assessment in Elderly People With Colorectal Cancer: A Prospective Study.
Antonio M; Carmona-Bayonas A; Saldaña J; Navarro V; Tebé C; Salazar R; Borràs JM
Clin Colorectal Cancer; 2018 Mar; 17(1):e59-e68. PubMed ID: 29054805
[TBL] [Abstract][Full Text] [Related]
7. Physical exercise program to older frail patients receiving chemotherapy for colorectal cancer - feasibility and experiences from the GERICO study.
Olsen AP; Vinther A; Ragle AM; Dolin TG; Johansen JS; Vistisen K; Nielsen DL; Lund CM
J Geriatr Oncol; 2023 Jan; 14(1):101382. PubMed ID: 36328878
[TBL] [Abstract][Full Text] [Related]
8. Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial.
Winther SB; Liposits G; Skuladottir H; Hofsli E; Shah CH; Poulsen LØ; Ryg J; Osterlund P; Berglund Å; Qvortrup C; Glimelius B; Sorbye H; Pfeiffer P
Lancet Gastroenterol Hepatol; 2019 May; 4(5):376-388. PubMed ID: 30852136
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for colorectal cancer in the elderly.
Kim JH
World J Gastroenterol; 2015 May; 21(17):5158-66. PubMed ID: 25954089
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.
Seymour MT; Thompson LC; Wasan HS; Middleton G; Brewster AE; Shepherd SF; O'Mahony MS; Maughan TS; Parmar M; Langley RE; ;
Lancet; 2011 May; 377(9779):1749-59. PubMed ID: 21570111
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study.
Mahmoud AM; Biello F; Maggiora PM; Bruna R; Burrafato G; Cappelli M; Varughese F; Martini V; Platini F; Deambrogi C; Patriarca A; Nicolosi M; Vachanaram AR; Pisani C; Ferrara E; Catania E; Azzolina D; Barone-Adesi F; Krengli M; Gaidano G; Gennari A
BMC Geriatr; 2021 May; 21(1):320. PubMed ID: 34011271
[TBL] [Abstract][Full Text] [Related]
12. A systematic overview of chemotherapy effects in colorectal cancer.
Ragnhammar P; Hafström L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
[TBL] [Abstract][Full Text] [Related]
13. Randomised study of tegafur-uracil plus leucovorin versus capecitabine as first-line therapy in elderly patients with advanced colorectal cancer--TLC study.
Kroep JR; van Werkhoven E; Polee M; van Groeningen CJ; Beeker A; Erdkamp F; Weijl N; van Bochove A; Erjavec Z; Kapiteijn E; Stiggelbout AM; Nortier HW; Gelderblom H
J Geriatr Oncol; 2015 Jul; 6(4):307-15. PubMed ID: 26073532
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older.
Popescu RA; Norman A; Ross PJ; Parikh B; Cunningham D
J Clin Oncol; 1999 Aug; 17(8):2412-8. PubMed ID: 10561304
[TBL] [Abstract][Full Text] [Related]
15. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.
Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH
Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824
[TBL] [Abstract][Full Text] [Related]
16. Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysis.
Ward P; Hecht JR; Wang HJ; Dichmann R; Liem AK; Chan D; Patel R; Hu EH; Tchekmedyian NS; Wainberg ZA; Naeim A
J Geriatr Oncol; 2014 Oct; 5(4):368-75. PubMed ID: 25002322
[TBL] [Abstract][Full Text] [Related]
17. Frailty status but not age predicts complications in elderly cancer patients: a follow-up study.
Ørum M; Gregersen M; Jensen K; Meldgaard P; Damsgaard EMS
Acta Oncol; 2018 Nov; 57(11):1458-1466. PubMed ID: 30280625
[TBL] [Abstract][Full Text] [Related]
18. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy for colorectal carcinoma in the elderly].
Kächele V; Hahn P; Adler G; Seufferlein T
Z Gastroenterol; 2004 Oct; 42(10):1189-98. PubMed ID: 15508061
[TBL] [Abstract][Full Text] [Related]
20. The effect of comprehensive geriatric assessment on care received, treatment completion, toxicity, cancer-related and geriatric assessment outcomes, and quality of life for older adults receiving systemic anti-cancer treatment: A systematic review.
Disalvo D; Moth E; Soo WK; Garcia MV; Blinman P; Steer C; Amgarth-Duff I; Power J; Phillips J; Agar M
J Geriatr Oncol; 2023 Nov; 14(8):101585. PubMed ID: 37573197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
